4//SEC Filing
Smith Edward B III 4
Accession 0001553350-22-000009
CIK 0001476963other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:19 PM ET
Size
8.2 KB
Accession
0001553350-22-000009
Insider Transaction Report
Form 4
Smith Edward B III
Director
Transactions
- Other
Stock Option (right to buy)
2021-12-30−32,467→ 0 totalExercise: $4.06From: 2022-01-13Exp: 2031-12-12→ Common Stock (32,467 underlying) - Award
Stock Option (right to buy)
2021-12-30+32,467→ 32,467 totalExercise: $4.06From: 2021-01-13Exp: 2031-12-29→ Common Stock (32,467 underlying)
Footnotes (2)
- [F1]On December 30, 2021, the board of directors of Heat Biologics, Inc. (the "Company") rescinded and cancelled stock option awards previously made to Mr. Smith on December 13, 2021 covering 32,467 shares under the Company's 2018 Stock Incentive Plan (the "Plan") and granted new stock options under the Plan, on substantially similar terms to the rescinded stock options, which new stock options are subject to forfeiture in the event an amendment to increase the number of shares of common stock available for grant under the Plan is not adopted by the Company's stockholders.
- [F2]These stock options vest pro rata on a monthly basis over a twelve- month period commencing 1/13/2022.
Documents
Issuer
HEAT BIOLOGICS, INC.
CIK 0001476963
Entity typeother
Related Parties
1- filerCIK 0001436316
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:19 PM ET
- Size
- 8.2 KB